Colin Stott

Geschäftsführer bei ALTEROLA BIOTECH, INC.

Vermögen: 173 850 $ am 31.05.2026

59 Jahre

30 Beziehungen

Health Technology

Process Industries

Consumer Services

Profil

Colin G.
Stott is the founder of Phytotherapeutix Holdings Ltd., founded in 2020, serving as Chief Executive Officer.
Mr. Stott is the founder of Phytotherapeutix Ltd., founded in 2019, serving as Chief Executive Officer.
Current jobs include Independent Director at Cardiol Therapeutics, Inc. since 2019 and Chief Operating Officer & Director at Alterola Biotech, Inc. since 2021.
Former jobs include Chief Operating Officer & Director at Alterola Biotech, Inc. (California), Director at Protagenic Therapeutics, Inc. in 2025, Director-Scientific Affairs at GW Pharmaceuticals Ltd. from 2017 to 2019, Manager-Clinical Projects at Phytopharm Plc in 1999, Manager-Clinical Programme at Napp Pharmaceuticals Ltd. in 1990, and Chief Operating Officer at Alinova Biosciences Ltd. from 2019 to 2020.
Education includes undergraduate studies at Loughborough University.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
CARDIOL THERAPEUTICS INC. CLASS A 0,13 %	03.12.2025	142 500 ( 0,13 % )	173 850 $	31.05.2026

Aktive Positionen von Colin Stott

Unternehmen	Position	Beginn
ALTEROLA BIOTECH, INC.	Geschäftsführer	21.06.2021
CARDIOL THERAPEUTICS INC.	Direktor/Vorstandsmitglied	03.12.2019
Phytotherapeutix Holdings Ltd.	Vorstandsvorsitzender	01.11.2020
Phytotherapeutix Ltd.	Vorstandsvorsitzender	01.04.2019

Alle aktiven Positionen von Colin Stott

Ehemalige bekannte Positionen von Colin Stott

Unternehmen	Position	Ende
PROTAGENIC THERAPEUTICS, INC.	Geschäftsführer	08.08.2025
Alinova Biosciences Ltd.	Geschäftsführer	01.12.2020
GW PHARMACEUTICALS PLC	Corporate Officer/Principal	01.05.2019
Phytopharm Plc Phytopharm Plc Pharmaceuticals: MajorHealth Technology Engages in developing novel treatments targeting diseases	Corporate Officer/Principal	01.01.1999
Napp Pharmaceuticals Ltd. Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Corporate Officer/Principal	02.01.1990

Sehen Sie sich die Erfahrung von Colin Stott im Detail an

Ausbildung von Colin Stott

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Colin Stott im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	11
Alterola Biotech, Inc. (California) Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums	Process Industries
Phytopharm Plc Phytopharm Plc Pharmaceuticals: MajorHealth Technology Engages in developing novel treatments targeting diseases	Health Technology
GW Pharmaceuticals Ltd. GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics	Health Technology
Napp Pharmaceuticals Ltd. Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Health Technology
Loughborough University Loughborough University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Protagenic Therapeutics, Inc. Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders	Health Technology
Cardiol Therapeutics, Inc. Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease	Health Technology
Alinova Biosciences Ltd.
Alterola Biotech, Inc. Alterola Biotech, Inc. Pharmaceuticals: OtherHealth Technology Develops medical cannabis products	Health Technology
Phytotherapeutix Holdings Ltd.
Phytotherapeutix Ltd.